These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7396882)

  • 1. Kinetic measurements of the biliary excretion of metabolized compounds.
    Powell GM; Jones JG; Curtis CG
    Biochem J; 1980 May; 188(2):561-4. PubMed ID: 7396882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cholic acid and dehydrocholic acid on the biliary excretion of unconjugated and conjugated sulfobromophthalein in rats.
    Schulze PJ; Czok G; Meyer H
    Arzneimittelforschung; 1976; 26(10):1894-903. PubMed ID: 1037210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: The influence of cholic acid (CA) and dehydrocholic acid (DCA) on the biliary excretion of sulfobromophthalein (BSP) and of BSP-GSH in rats.
    Schulze PJ; Czok G; Meyer H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R70. PubMed ID: 1143483
    [No Abstract]   [Full Text] [Related]  

  • 4. Diminution of bile flow and of liver uptake and biliary excretion of bromsulphthalein by aldosterone.
    Afifi F
    Tohoku J Exp Med; 1981 Oct; 135(2):139-47. PubMed ID: 7330862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary excretion of phenolphthalein sulfate in rats.
    Tanaka H; Sano N; Takikawa H
    Pharmacology; 2003 Aug; 68(4):177-82. PubMed ID: 12837971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary cefpiramide excretion: its relation to biliary excretion of bile acids and sulfobromophthalein.
    Takikawa H; Uchida Y; Sano N; Yamanaka M
    Pharmacology; 1995 Jun; 51(1):24-32. PubMed ID: 7568341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirex-induced impairment of hepatobiliary function. Suppressed biliary excretion of imipramine and sulfobromophthalein.
    Mehendale HM
    Drug Metab Dispos; 1977; 5(1):56-62. PubMed ID: 13976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress.
    Lauterburg BH; Smith CV; Hughes H; Mitchell JR
    J Clin Invest; 1984 Jan; 73(1):124-33. PubMed ID: 6690473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective hepatic uptake and biliary excretion of 35S-sulfobromophthalein in marine elasmobranchs.
    Boyer JL; Schwarz J; Smith N
    Gastroenterology; 1976 Feb; 70(2):254-6. PubMed ID: 1248686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat.
    Takikawa H; Sano N; Narita T; Uchida Y; Yamanaka M; Horie T; Mikami T; Tagaya O
    Hepatology; 1991 Aug; 14(2):352-60. PubMed ID: 1860692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and biliary excretion of sulfobromophthalein in vitamin A deficiency.
    Siddik ZH; Drew R; Gram TE
    Biochem Pharmacol; 1980 Oct; 29(19):2583-8. PubMed ID: 7426064
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of bromosulphophthalein, indocyanine green and bilirubin on the biliary excretion of methylmercury.
    Magos L; Clarkson TW; Allen J; Snowden R
    Chem Biol Interact; 1979 Aug; 26(3):317-20. PubMed ID: 509694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies in blood, bile and urine to the biliary excretion and multicompartmental analysis of glycocholic acid in the unanaesthezized pig (author's transl)].
    Klapdor R; Bolte J; Schlosser GA
    Res Exp Med (Berl); 1975 Dec; 166(3):209-19. PubMed ID: 1215666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of preexposure to kepone on the biliary excretion of imipramine and sulfobromophthalein.
    Mehendale HM
    Toxicol Appl Pharmacol; 1977 May; 40(2):247-59. PubMed ID: 69337
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates.
    Cowen AE; Korman MG; Hofmann AF; Cass OW
    Gastroenterology; 1975 Jul; 69(1):59-66. PubMed ID: 1150035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate induction of the biliary excretion of sulfobromophthalein in rats.
    Fischer E; Varga F; Gregus Z
    Biochem Pharmacol; 1984 May; 33(9):1557-9. PubMed ID: 6732869
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of the enzymatic activity of ligandin by organogermanium, organolead or organotin compounds and the biliary excretion of sulfobromophthalein by the rat.
    Byington KH; Hansbrough E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):248-53. PubMed ID: 762656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary transport of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors conjugated with bile acids.
    Petzinger E; Nickau L; Horz JA; Schulz S; Wess G; Enhsen A; Falk E; Baringhaus KH; Glombik H; Hoffmann A
    Hepatology; 1995 Dec; 22(6):1801-11. PubMed ID: 7489992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and ileal transport and effect on biliary secretion of norursocholic acid and its conjugates in rats.
    Lillienau J; Hagey LR; Borgström B
    Am J Physiol; 1991 Dec; 261(6 Pt 1):G1057-64. PubMed ID: 1767847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfobromophthalein metabolism in isolated perfused rat liver. Factors determining the applicability of the model.
    Céspedes JM; Rodríguez Garay EA
    Acta Physiol Lat Am; 1979; 29(4-5):207-15. PubMed ID: 263170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.